ACS Medicinal Chemistry Letters · 2019 · 10 citations · 21 references
PharmacyInfectious DiseasesMedicinal ChemistryDrug DiscoveryMolecular VirologyVirologyAntiviral AgentsAntiviral PharmacologyAntiviral Prodrug DesignAntiviral TherapyMicrotubule-targeting AgentsViral InfectionsAntiviral Drug DesignAntiviral SpectrumAntiviral TherapeuticsBroad-spectrum Antiviral AgentsHost Factor DependencySite-directed CleavageTargeted Prodrug ActivationViral Proteases
Infections with flaviviruses such as dengue virus (DENV) are prevalent throughout tropical regions worldwide. Replication of these viruses depends on tubulin, a host cell factor that can be targeted to obtain broad-spectrum antiviral agents. Targeting of tubulin does, however, require specific measures to avoid toxic side-effects. Herein, we report the synthesis and biological evaluation of combretastatin peptide hybrids that incorporate the cleavage site of the DENV protease to allow activation of the tubulin ligand within infected cells. The prodrug candidates have no effect on tubulin polymerization in vitro and are 20–2000-fold less toxic than combretastatin A-4. Several of the prodrug candidates were cleaved by the DENV protease in vitro with similar efficiency as the natural viral substrates. Selected compounds were studied in DENV and Zika virus replication assays and had antiviral activity at subcytotoxic concentrations.
21
WebLogo: A Sequence Logo Generator: Figure 1
Gavin E. Crooks, Gary C. Hon, John‐Marc Chandonia et al. · Genome Research · 2004 · 13K citations · Full text
The global distribution and burden of dengue
Samir Bhatt, Peter W. Gething, Oliver J. Brady et al. · Nature · 2013 · 10.2K citations · Full text
Public Health, Infectious Disease Control, Infectious Diseases +12
Neil D. Rawlings, A. John Barrett, Paul D. Thomas et al. · Nucleic Acids Research · 2017 · 1.8K citations · Full text